
Sign up to save your podcasts
Or
Dr. David Almeida discusses the result of his group's large retrospective analysis of management and outcomes of 40 cases of endophthalmitis from over 258,000 intravitreal anti-VEGF injections.
Full reference:
Xu, K., Chin, E. K., Bennett, S. R., Williams, D. F., Ryan, E. H., Dev, S., . . . Almeida, D. R. P. (2018). Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes. Ophthalmology. doi:10.1016/j.ophtha.2018.01.022
4.4
1111 ratings
Dr. David Almeida discusses the result of his group's large retrospective analysis of management and outcomes of 40 cases of endophthalmitis from over 258,000 intravitreal anti-VEGF injections.
Full reference:
Xu, K., Chin, E. K., Bennett, S. R., Williams, D. F., Ryan, E. H., Dev, S., . . . Almeida, D. R. P. (2018). Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes. Ophthalmology. doi:10.1016/j.ophtha.2018.01.022
43 Listeners
17 Listeners
5 Listeners
442 Listeners
20 Listeners
10 Listeners
50 Listeners
10 Listeners
1 Listeners
18 Listeners
16 Listeners
0 Listeners
16 Listeners
0 Listeners
0 Listeners